STOCK TITAN

Northwest Biotherapeutics Inc - NWBO STOCK NEWS

Welcome to our dedicated news page for Northwest Biotherapeutics (Ticker: NWBO), a resource for investors and traders seeking the latest updates and insights on Northwest Biotherapeutics.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Northwest Biotherapeutics's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Northwest Biotherapeutics's position in the market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.29%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.29%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.52%
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
9.33%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.14%
Tags
acquisition
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.14%
Tags
acquisition
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
6.06%
Tags
none
-
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.71%
Tags
none
Northwest Biotherapeutics Inc

OTC:NWBO

NWBO Rankings

NWBO Stock Data

617.59M
1.11B
10.04%
0.25%
11.34%
Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
Bethesda

About NWBO

northwest biotherapeutics, inc. is a development stage biotechnology company focused on discovering, developing and commercializing immunotherapy products that generate and enhance immune system responses to treat cancer. currently approved cancer treatments are frequently ineffective, can cause undesirable side effects and provide marginal clinical benefits. the company’s approach in developing cancer therapies utilizes its expertise in the biology of dendritic cells, which are a type of white blood cell that activate the immune system. the company’s cancer therapies have been demonstrated in clinical trials to significantly extend both time to recurrence and survival, whilst providing a superior quality of life with no debilitating side effects when compared with current therapies. the company’s platform technology, dcvax®, uses a patient’s own dendritic cells, the starter engine of the immune system. the dendritic cells are extracted from the body, loaded with tumor biomarkers or ‘‘